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INTRODUCTION
Placenta percreta is a subtype of placenta accreta
in which the placenta invades the entire uterine wall
and affects the adjacent organs. The incidence of
placenta accreta ranges from one in 530 to one in
2,500 deliveries, and its incidence has been increas-
ing due to an increase in cesarean sections (1). Ce-
sarean sections with placenta percreta is mostly per-
formed under general anesthesia. However, it is a
condition with a high surgical risk and generally re-
quires an obstetric hysterectomy to control massive
hemorrhage. It has been reported to have a mor-
tality rate up to 7% (2). We report a case of placenta
percreta with massive hemorrhage where a cell
salvage device (Cell Saver ; Haemonetics Japan)
and a rapid infuser (LEVEL 1 SYSTEM 1000 ;
Smith Medical Japan Ltd.) were life saving and ef-
fective.
CASE PRESENTATION
The patient was a 39-year-old woman who was
157 cm in height and 58 kg in weight. She had four
previous children, two of which had been delivered
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by cesarean section. She was diagnosed with pla-
centa percreta by magnetic resonance imaging with
a high suspicion that there was invasion into the
muscularis of the bladder (Figure 1). Therefore, ce-
sarean section was planned at 33 weeks of gestation.
However, at 27 weeks of gestation, she underwent an
emergency cesarean section due to vaginal bleeding
and an intrauterine infection. We planned a cesarean
section without exfoliating the placenta and cesar-
ean hysterectomy. Pre-operative laboratory data are
shown in Table 1. General anesthesia was induced
using propofol, remifentanil, and rocuronium and an-
esthesia was maintained using propofol, fentanyl,
and remifentanil. Figure 2 shows the anesthetic
chart including hemodynamics and laboratory data.
During the surgery, because the uterine surface was
highly vascularized due to the placenta percreta,
the decision was made to avoid surgical resection
of the placenta and to directly dissect the uterine
base with a vertical incision and perform a com-
plete hysterectomy and partial cystectomy. How-
ever, hemostasis became difficult because the blad-
der invasion by the placenta was abundant. Bleeding
was ultimately controlled following bilateral inter-
nal iliac artery embolization. Furthermore, we used
catecholamines (dopamine and norepinephrine),
a cell salvage device (Cell Saver ; Haemonetics
Japan) and a rapid infuser (LEVEL 1 SYSTEM
1000 ; Smith Medical Japan Ltd.) for hemodynamic
stabilization. Intra-operative bleeding was 47,000 mL
and total anesthesia time was 12 h and 47 min. A
total of 120 units of red blood cells, 90 units of fresh
frozen plasma, and 100 units of platelets were trans-
fused. After the surgery, the patient was transferred
to the intensive care unit and was extubated 9 hours
later. Post-operative laboratory data are also shown
in Table 1. She was discharged on the 32th post-
operative day without major complications.
The baby (898 g) was born 7 min after the opera-
tion had started and was intubated immediately after
birth with Apgar scores of 1 and 5 at 1 minute and
5 minutes, respectively. The baby was extubated 17
days after birth and discharged after the 95th day.
Figure 1. Magnetic resonance imaging of the plevis revealed invasion into the bladder by the placenta (red arrow).
Table 1. Vital sign and laboratory data before and after opera-
tion
Before After
1hour 6hours Day1 Day3
HR (beat/min) 111 64 85 58 60
SBP (mmHg) 82 146 113 148 115
DBP (mmHg) 34 78 69 77 65
SpO2 (%) 98 100 100 98 100
Hb (g/dL) 9.5 8.2 9.0 8.1 12.7
Plt (1000/μL) 155 63 48 29 112
PT-INR 0.92 1.36 1.37 0.99 0.96
APTT (s) 28.2 46.9 35.9 29.0 27.4
Fibrinogen (mg/dL) 484 167 305 447 501
BUN (mg/dL) 6 11 15 31 8
Creatinine (mg/dL) 0.46 0.58 0.9 1.10 0.69
Sodium (mEq/L) 133 147 146 146 143
Potassium (mEq/L) 3.5 3.3 3.4 3.4 2.7
Chloride (mEq/L) 101 113 112 112 110
HR=Heart rate, SBP=Systolic blood pressure, DBP=Diastolic
blood pressure, SPO2=Saturation of peripheral oxygen, Hb=
Hemoglobin, Plt=Platelets, PT-INR=Prothrombin time and inter-
national normalized rate, APTT=Activated partial thromboplastin
time, BUN=Blood urea nitrogen.
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DISCUSSION
Placenta percreta is a rare subtype of placenta
accreta in which the placenta invades the entire
uterine wall and affects the adjacent organs (Table
2). It is a condition with a high surgical risk and
generally requires an obstetric hysterectomy. Pla-
centa accreta has been reported to have up to a 7%
mortality rate as well as intra-operative and post-
operative morbidity associated with massive blood
transfusions, infection, ureteral damage, and fistula
formation (2). Prior delivery by cesarean section is
a risk factor for placenta accreta. According to a re-
port by Sumigama et al. (3), among 59,008 deliver-
ies, 408 cases were diagnosed as placenta previa ;
of these, 18 cases were placenta increta and 5 of
placenta percreta. Mean intra-operative blood loss
was 3,6302,216 mL (increta) and 12,1408,343
mL (percreta). One patient with placenta percreta
died of hemorrhage (3).
Figure 2. Anesthetic chart
Table 2. Summary of reported case of placenta percreta
Authors
(Reference number)
Year Method of
diagnosis
Amount of transfusion
(Red blood cells)
Treatments
Abbas et al (11) 2000 ultrasound 22 hysterectomy, bladder repair, bilateral internal iliac artery ligation
Abbas et al (11) 2000 ultrasound 15 hysterectomy, bladder repair, bilateral internal iliac artery ligation
Caliskan et al (12) 2003 ultrasound 13 hysterectomy, bladder repair, bilateral hypogastric artery ligation,
abdominal packing
Takai et al (13) 2005 ultrasound
MRI
cystoscopy
35 hysterectomy, bladder repair, bilateral internal iliac artery ligation
Shawish et al (14) 2007 ultrasound
MRI
cystoscopy
5 hysterectomy, bladder repair
Matsubara et al (15) 2009 ultrasound
MRI
8+2(autologous) hysterectomy, bladder repair,
bilateral internal iliac artery balloon catheters occlusion
Parva et al (16) 2009 ultrasound
MRI
2 hysterectomy, bladder repair,
bilateral internal iliac artery balloon catheters occlusion
Sijanovic et al (17) 2011 no diagnosis
before surgery
20 hysterectomy, bladder repair, bilateral hypogastric artery ligation
Reitman et al (18) 2011 ultrasound 3 hysterectomy, bladder repair, uterine artery ligation
Vahdat et al (19) 2012 ultrasound 20 radical parametrectomy, bilateral internal iliac artery ligation,
abdominal packing
Sultan et al (20) 2012 ultrasound 16 hysterectomy, bladder repair
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In 1997, Dubois et al. reported that temporary bal-
loon occlusion of the bilateral internal iliac artery is
a method to control bleeding during cesarean hys-
terectomy for placenta percreta (4). However, in this
emergency case, the patient presented with vagi-
nal bleeding and had an intrauterine infection, pre-
venting any pre-operatively planning. Ultimately, bi-
lateral internal iliac artery embolization was per-
formed intra-operatively to control hemorrhaging
and achieve hemodynamic stability. Ideally, multi-
disciplinary pre-operative planning with the depart-
ments of obstetrics and gynecology, radiology, and
anesthesiology will be optimal in future cases.
A decrease in fibrinogen is one of the leading fac-
tors involved in postpartum massive hemorrhage.
Bleeding of2,000 mL ; can result in dilutional co-
agulopathy. When massive hemorrhage occurs, fi-
brinogen is the first coagulation factor that becomes
depleted resulting in coagulopathy. This is because
other coagulation factors can deplete up to 80% of
normal concentrations before coagulopathy is ob-
served, whereas fibrinogen can only lose up to 60%
of normal concentrations (100 mg/dL) before co-
agulopathy (5). Fresh frozen plasma (FFP) is used
to increase the fibrinogen concentrations. However,
when massive hemorrhaging persists, administration
of FFP cannot be expected to effectively supplement
the fibrinogen concentrations (6). Moreover, there
is a report that administration of a large quantity of
FFP is associated with acute lung injury (7). In this
case, although the patient did not develop acute
lung injury, we should prepare a cryoprecipitate by
concentrating FFP to 10 times, when massive hem-
orrhage was expected (8).
Cell Saver is a cell salvage device used during
surgery to avoid allogeneic transfusions and the ele-
vation of serum potassium concentration. Cell sal-
vage has been used in obstetrics to a limited degree
because of the fear of amniotic fluid embolism al-
though the exact mechanism is still unclear. In con-
trast, leukocyte depletion filtering of cell-salvaged
blood obtained from cesarean section reduces am-
niotic fluid components to a concentration equivalent
to maternal venous blood (9). This device has been
reportedly used safely in400 cases (4, 10). In this
case, the patient did not develop an amniotic fluid
embolus. Moreover, Cell Saver reduced the need
for allogeneic transfusions and avoided the elevation
of serum potassium concentration. During surgery
the patient’s serum potassium concentration in-
creased up to 7.6 mmol/L, but returned to a normal
concentrations after using this device.
We describe a difficult case of placenta percreta
with massive hemorrhage, where transfusions alone
were not sufficient to maintain hemodynamics. The
use of a cell salvaging device and rapid infuser,
which are not routinely available during these pro-
cedures were required to maintain hemodynamic
stability. Ultimately, it is critical to have multidisci-
plinary pre-operative discussions regarding strategic
planning and potential complications in difficult cases
such as these. Furthermore, pre-operative prepara-
tion of a Cell Saver and LEVEL 1 SYSTEM 1000
with appropriate staffing is essential in cases where
massive blood loss is expected.
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